Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 286 AL 300

The Clinician's Interview-Based Impression of Change (Plus caregiver input) and goal attainment in two dementia drug trials: Clinical meaningfulness and the initial treatment response

Stanley J, Howlett SE, Dunn T, Rockwood K.

Alzheimers Dement. 2021 May;17(5):856-865. doi: 10.1002/alz.12242. Epub 2021 Apr 29.

mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder

Perluigi M, Di Domenico F, Barone E, Butterfield DA.

Free Radic Biol Med. 2021 Jun;169:382-396. doi: 10.1016/j.freeradbiomed.2021.04.025. Epub 2021 Apr 30.

The Role of the Microbiota-Gut-Brain Axis in the Health and Illness Condition: A Focus on Alzheimer's Disease

De la Fuente M.

J Alzheimers Dis. 2021;81(4):1345-1360. doi: 10.3233/JAD-201587.

A Review of the Application of Hyperbaric Oxygen Therapy in Alzheimer's Disease

Somaa F.

J Alzheimers Dis. 2021;81(4):1361-1367. doi: 10.3233/JAD-210157.

Possible effects of Porphyromonas gingivalis on the blood-brain barrier in Alzheimer's disease

Olsen I.

Expert Rev Anti Infect Ther. 2021 Nov;19(11):1367-1371. doi: 10.1080/14787210.2021.1925540. Epub 2021 May 13.

Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies

Jangampalli Adi P, Reddy PH.

Biochim Biophys Acta Mol Basis Dis. 2021 Aug 1;1867(8):166162. doi: 10.1016/j.bbadis.2021.166162. Epub 2021 Apr 30.

The connections of Locus Coeruleus with hypothalamus: potential involvement in Alzheimer's disease

Giorgi FS, Galgani A, Puglisi-Allegra S, Busceti CL, Fornai F.

J Neural Transm (Vienna). 2021 May;128(5):589-613. doi: 10.1007/s00702-021-02338-8. Epub 2021 May 3.

Meta-Analysis of Methamphetamine Modulation on Amyloid Precursor Protein through HMGB1 in Alzheimer's Disease

Alabed S, Zhou H, Sariyer IK, Chang SL.

Int J Mol Sci. 2021 Apr 30;22(9):4781. doi: 10.3390/ijms22094781.

Dysbiosis and Alzheimer's Disease: A Role for Chronic Stress?

Sharma VK, Singh TG, Garg N, Dhiman S, Gupta S, Rahman MH, Najda A, Walasek-Janusz M, Kamel M, Albadrani GM, Akhtar MF, Saleem A, Altyar AE, Abdel-Daim MM.

Biomolecules. 2021 Apr 30;11(5):678. doi: 10.3390/biom11050678.

Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran

Grossmann K.

Int J Mol Sci. 2021 Apr 30;22(9):4805. doi: 10.3390/ijms22094805.

Progress with Treatments for Alzheimer's Disease

Levey AI.

N Engl J Med. 2021 May 6;384(18):1762-1763. doi: 10.1056/NEJMe2103722.

Oxidative Stress, Neuroinflammation, and NADPH Oxidase: Implications in the Pathogenesis and Treatment of Alzheimer's Disease

Ganguly U, Kaur U, Chakrabarti SS, Sharma P, Agrawal BK, Saso L, Chakrabarti S.

Oxid Med Cell Longev. 2021 Apr 16;2021:7086512. doi: 10.1155/2021/7086512. eCollection 2021.

Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer's disease and insomnia: A systematic review and meta-analysis of randomized controlled trials

Sumsuzzman DM, Choi J, Jin Y, Hong Y.

Neurosci Biobehav Rev. 2021 Aug;127:459-473. doi: 10.1016/j.neubiorev.2021.04.034. Epub 2021 May 3.

Longitudinal predictive modeling of tau progression along the structural connectome

Yang F, Chowdhury SR, Jacobs HIL, Sepulcre J, Wedeen VJ, Johnson KA, Dutta J.

Neuroimage. 2021 Aug 15;237:118126. doi: 10.1016/j.neuroimage.2021.118126. Epub 2021 May 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias